JNCI Press Room - Archived Press Releases
November 10, 2009
Erythropoiesis-Stimulating Agents Associated with Higher Risk of Venous Thromboembolism Use of erythropoiesis-stimulating agents is associated with an increased risk of venous thromboembolism, according to study published online November 10 in the JNCI.
November 5, 2009
Higher Incidence of Thyroid Cancer in Volcanic Area of Sicily People living in volcanic areas may be at a higher risk for thyroid cancer, according to a new study published online November 5 in the JNCI.
October 26, 2009
Holocaust Survivors at Higher Risk for All Cancers
Jewish survivors of World War II who were potentially exposed to the Holocaust are at a higher risk for cancer occurrence, according to a new study published online October 26 in the JNCI.
October 12, 2009
Proactive, Personalized Telephone Counseling Can Help Teen Smokers to Quit Personalized, proactive telephone counseling centered on motivational interviewing and cognitive behavioral skills training has been found to favorably impact quit rates among teen smokers, according to a pair of studies published online October 12 in the JNCI.
September 24, 2009
Cost-Savings of Colorectal Cancer Screening as Treatment Costs Increase Investing in some colorectal cancer screening programs could cut future, more expensive treatment costs in half, according to a new study published online September 24 in the JNCI. The only screening program found not to be cost-saving was colonoscopy.
September 16, 2009
Cases of Liver Cancer Reduced in a Younger Population Vaccinated for HBV A 20-year follow-up study revealed a dramatic drop in liver cancer cases among 6- to 19-year-olds who were vaccinated for the hepatitis B virus at birth, according to a study published online September 16 in the JNCI.
August 31, 2009
Overdiagnosis Since Introduction of Prostate Cancer Screening The introduction of prostate-antigen screening, or PSA, has resulted in over 1 million additional men over the last 23 years being diagnosed and treated for prostate cancer—most of whom were likely overdiagnosed, researchers reported in a new study published online August 31 in JNCI.
August 21, 2009
Fecal DNA Methylation Detects Gastric and Colorectal Cancers A preliminary evaluation of methylation of two gene promoters in fecal DNA showed promise as a noninvasive method to detect colorectal and gastric cancers, according to a new study published online August 21 in the JNCI.
August 7, 2009
Cost-Effectiveness of Cetuximab in Metastatic Colorectal Cancer
From a health-care system perspective, it may be more efficient to use the drug cetuximab only in colorectal cancer patients whose tumors have a wild-type KRAS gene, according to a study published online August 7 in the JNCI.
August 5, 2009
Considering Combination vs. Sequential Chemotherapy in Metastatic Breast Cancer Both combination and sequential single-agent chemotherapy are reasonable options to treat metastatic breast cancer, but the choice between the two should ultimately be based on patient- and disease-related factors, according to a new commentary published online August 5 in the JNCI.
July 31, 2009
Risk of HPV–Associated Cancers Among Persons With AIDS Risk of human papillomavirus (HPV)-associated cancers is greater for people living with AIDS and increases with increasing immunosuppression, according to a new study published online July 31 in the JNCI.
Long-term Health and Social Outcomes for Neuroblastoma Survivors Survivors of the childhood cancer neuroblastoma are eight times more likely to have chronic health conditions, less likely to be married, and more likely to have lower incomes than their siblings, according to a new study published online July 31 in the JNCI.
July 7, 2009
Two Studies Shed Light on Racial Disparities in Cancer Survival Black women diagnosed with breast cancer have a greater chance of dying from the disease than white women, according to one new study published online July 7 in the JNCI. A second study also published online July 7 found that African American patients with sex-specific cancers had worse survival than white patients, despite their participation in phase III SWOG trials with uniform stage, treatment, and follow-up
June 29, 2009
How much is life worth? The $440 Billion Question The decision to use expensive cancer therapies that typically produce only a relatively short extension of survival is a serious ethical dilemma in the U.S. that needs to be addressed by the oncology community, according to a commentary published online June 29 in the JNCI.
June 26, 2009
Dietary Fat Linked to Pancreatic Cancer High intake of dietary fats from red meat and dairy products was associated with an increased risk of pancreatic cancer, according to a new study published online June 26 in the JNCI.
June 17, 2009
Promising Biomarker and Candidate Tumor Suppressor Gene Identified for Colorectal Cancer Researchers have identified a new candidate tumor suppressor gene in colorectal cancer and examined its use as a potential biomarker in stool samples, according to a new study published online June 17 in the JNCI.
Hodgkin Lymphoma Survivors Have Increased Risk of Stroke and Transient Ischemic Attack Patients treated for Hodgkin lymphoma with radiation therapy have a substantially higher risk of stroke, according to a new study published online June 17 in the JNCI.
Want to be added to the JNCI Press List? Reporters can email jncimedia@oxfordjournals.org to receive press releases of upcoming studies.
JNCI is now on Twitter! Follow the @JNCI_Now account to find out about the latest cancer studies and news published in the JNCI.
JNCI Podcast
